HighTower Advisors LLC Cuts Holdings in Cytokinetics, Incorporated (NASDAQ:CYTK)
HighTower Advisors LLC lessened its stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 13.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 9,323 shares of the biopharmaceutical company’s stock after selling 1,481 shares during the quarter. HighTower Advisors LLC’s holdings in Cytokinetics were worth $439,000 as of its most recent SEC filing. […]
HighTower Advisors LLC lessened its stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 13.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 9,323 shares of the biopharmaceutical company’s stock after selling 1,481 shares during the quarter. HighTower Advisors LLC’s holdings in Cytokinetics were worth $439,000 as of its most recent SEC filing. […]
